A CRISPR-Cas13d cancer therapeutic enables selective elimination of uveal melanoma
Author:
Daniel Stauber,Lucas Sosnick,Yitong Ma,Sopida Pimcharoen,Atip Lawanprasert,Niren Murthy,David Myung,Lei S. Qi
Publication:
Molecular Therapy: Oncology
© 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.